AGIOS PHARMACEUTICALS, INC. (AGIO) Operating margin 2016–2025
AGIOS PHARMACEUTICALS, INC. (AGIO) operating margin by fiscal year — reported operating income divided by reported revenue.
-873.9%FY2025 · since FY2016: -287.6% → -873.9%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -873.9% | +292.6 pp |
| FY2024 | -1166.5% | +293.1 pp |
| FY2023 | -1459.5% | +1272.6 pp |
| FY2022 | -2732.1% | — |
| FY2019 | -268.2% | +115.8 pp |
| FY2018 | -384.0% | +361.8 pp |
| FY2017 | -745.8% | -458.3 pp |
| FY2016 | -287.6% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More AGIO financial trends
AGIO RevenueAGIO Net incomeAGIO Net marginAGIO Gross profitAGIO Gross marginAGIO Operating incomeAGIO Operating cash flowAGIO Free cash flowAGIO Capital expendituresAGIO Return on equityAGIO Stock buybacksAGIO Dividends paidAGIO Total assetsAGIO Total liabilitiesAGIO Shareholders’ equityAGIO overview →